Collection of Blood and Bone Marrow From Healthy Volunteers and Patients for Research Purposes
2 other identifiers
observational
154
1 country
1
Brief Summary
This study is designed to provide bone marrow and/or blood cells for other research studies. Patients participating in this study will be asked to provide small amounts of medical information and undergo a limited physical examination designed to detect the presence of any obvious blood disease. A blood and bone marrow sample will be obtained to verify that the patient has normal blood cell production. Researchers plan to obtain bone marrow samples to be used in laboratory studies directed toward understanding the formation of blood cells. Bone marrow samples will be taken from the hip bone of patients and healthy volunteers. These samples are valuable to many research studies within the Hematology Branch of the National Heart, Lung, and Blood Institute, including studies of normal and abnormal production of blood cells, the viral causes of blood diseases, and the role of the immune system in bone marrow failure and related conditions....
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 1997
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 8, 1997
CompletedFirst Submitted
Initial submission to the registry
November 3, 1999
CompletedFirst Posted
Study publicly available on registry
November 4, 1999
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 22, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
December 22, 2010
CompletedOctober 8, 2020
October 1, 2020
13.5 years
November 3, 1999
October 5, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To provide a readily available supply of samples for blood and bone marrow for in vitro studies in the Hematology Branch laboratories
The collection of adequate cells for laboratory research.
Ongoing
Study Arms (1)
Group 1
Normal Volunteers and patients.
Eligibility Criteria
Normal Volunteers and patients
You may qualify if:
- Healthy volunteers age greater than or equal to 18 years.
- Subjects with hematologic disease age greater than or equal to 2 (for subjects less than 18, blood and bone marrow specimens will be obtained concurrently with clinically indicated sampling).
You may not qualify if:
- History of a significant bleeding disorder.
- Abnormal host-defense mechanisms.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, 20892, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Neal S Young, M.D.
National Heart, Lung, and Blood Institute (NHLBI)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 3, 1999
First Posted
November 4, 1999
Study Start
July 8, 1997
Primary Completion
December 22, 2010
Study Completion
December 22, 2010
Last Updated
October 8, 2020
Record last verified: 2020-10